Peptide reference chart

Every compound we track, grouped by goal and ordered by evidence strength.

43 shown

Compound	RCTs	Evidence	WADA	Vial	Diluent	Listed dose	Units 1 ml	Timing
Metabolic & fat loss
Semaglutide	593	FDA approved	not listed	3 mg	2 ml	250 mcg	17	Once weekly
Tirzepatide	182	FDA approved	not listed	10 mg	2 ml	0.5 mg	10	Morning
Tesamorelin	38	FDA approved	S2	10 mg	2 ml	1 mg	20	Morning / Evening
Retatrutide	15	Well researched	S0	10 mg	2 ml	0.5–1 mg	10–20	Morning
Cagrilintide	18	Emerging	S0	5 mg	2 ml	250 mcg	10	Morning
MOTS-c 503A	7	Emerging	S4	10 mg	2 ml	1 mg	20	Morning
Tesamorelin / Ipamorelin blend	—	Limited evidence	components	6 / 2 mg	2 ml	300 + 100 mcg	10	Morning / Evening
Triple Threat blend	—	Limited evidence	components	100/10/10 mg	2 ml	10 mg + 1 mg + 1 mg	20	Morning
5-Amino-1MQ	0	Limited evidence	S0	10 mg	2 ml	1 mg	20	Morning
AOD-9604	0	Limited evidence	S0	5 mg	2 ml	300 mcg	11	Morning
Healing & repair
ARA-290	2	Well researched	S0	15 mg	1 ml	1.5 mg	10	Daily
TB-500 503A	2	Emerging	S2	10 mg	2 ml	500 mcg	10	Morning
BPC-157 503A	0	Emerging	S0	10 mg	2 ml	500 mcg	10	Morning / Evening
GLOW blend	—	Limited evidence	components	50/10/10 mg	2 ml	2.5 mg + 500 + 500 mcg	10	Morning or Evening
KLOW blend	—	Limited evidence	components	50/10/10/10 mg	2 ml	2.5 mg + 3×500 mcg	10	Morning or Evening
BPC-157 / TB-500 blend	—	Limited evidence	components	5 / 5 mg	2 ml	250 + 250 mcg	10	Morning / Evening
Longevity
SS-31	15	Emerging	S0	10 mg	2 ml	500 mcg	10	Daily
CJC-1295 (no DAC)	2	Emerging	S2	10 mg	3 ml	200 mcg	6	Evening
NAD+	2	Emerging	—	500 mg	5 ml	100 mg	100	Morning
Thymalin / Thymogen	2	Limited evidence	—	20 mg	2 ml	2 mg	20	Evening
Epitalon 503A	0	Limited evidence	S0	20 mg	2 ml	2 mg	20	Evening
FOXO4-DRI	0	Limited evidence	S0	10 mg	2 ml	1 mg	20	Morning
Immunity
VIP	156	Well researched	—	5 mg	5 ml	50 mcg	5	Morning / Evening
Thymosin Alpha-1	55	Well researched	—	10 mg	2 ml	1.5 mg	30	Morning
LL-37	40	Emerging	S0	5 mg	2 ml	125 mcg	5	Morning
KPV 503A	0	Emerging	S0	10 mg	2 ml	500 mcg	10	Morning
Cognition & mood
Selank	2	Emerging	—	30 mg	3 ml	1 mg	10	Morning
Semax 503A	2	Emerging	—	30 mg	3 ml	1 mg	10	Morning
PE-22-28	1	Limited evidence	S0	10 mg	2 ml	250 mcg	5	Morning
P21	0	Limited evidence	S0	10 mg	2 ml	250 mcg	5	Morning
Sexual health
Oxytocin	2912	FDA approved	not listed	10 mg	10 ml	50 mcg	5	As needed
PT-141	6	FDA approved	not listed	10 mg	2 ml	500 mcg	10	Before activity
Kisspeptin-10	13	Well researched	S0	5 mg	2 ml	125 mcg	5	Before bed
Muscle & performance
L-Carnitine	735	Extensively studied	IV limits	600 mg/ml	N/A	200–600 mg	33–100	Morning
Ipamorelin	2	Emerging	S2	10 mg	3 ml	300 mcg	9	Morning / Evening
IGF-1 LR3	1	Limited evidence	S2	1 mg	1 ml	50 mcg	5	Morning
Follistatin 344	0	Limited evidence	S4	1 mg	2 ml	50 mcg	10	Pre-training (IM)
Hormonal support
HCG	1081	FDA approved	S2 (M)	5000 IU	2 ml	250–500 IU	10–20	Morning
HMG	202	FDA approved	S2 (M)	75 IU	0.5 ml	75 IU	50	Morning
Sermorelin	23	Well researched	S2	10 mg	2 ml	250 mcg	5	Evening
Sleep
DSIP 503A	6	Limited evidence	S0	5 mg	2 ml	250 mcg	10	1–3 h before bed
Skin & cosmetic
GHK-Cu	2	Well researched	S0	50 mg	3 ml	1.7 mg	10	Morning
Melanotan I	2	Well researched	—	10 mg	2 ml	250 mcg	5	Morning

Injectable bio-regulators

Fifteen compounds sharing one protocol.

Bio-regulator	Target	Vial	Diluent	Listed dose	Units
Bronchogen	Lungs	20 mg	2 ml	2 mg	20
Cardiogen	Heart	20 mg	2 ml	2 mg	20
Cartalax	Joints	20 mg	2 ml	2 mg	20
Chonluten	Respiratory	20 mg	2 ml	2 mg	20
Cortagen	Brain	20 mg	2 ml	2 mg	20
Livagen	Liver	20 mg	2 ml	2 mg	20
Ovagen	Liver / stomach	20 mg	2 ml	2 mg	20
Pancragen	Pancreas	20 mg	2 ml	2 mg	20
Pinealon	Brain	20 mg	2 ml	2 mg	20
Prostamax	Prostate	20 mg	2 ml	2 mg	20
Testagen	Male hormones	20 mg	2 ml	2 mg	20
Thymagen	Immune	20 mg	2 ml	2 mg	20
Vesugen	Vascular	20 mg	2 ml	2 mg	20
Vesilute	Bladder / prostate	20 mg	2 ml	2 mg	20
Vilon	Thymus / inflammation	20 mg	2 ml	2 mg	20